(Q40245317)

English

Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis

scientific article published on February 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

0 references

Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

0 references

1 reference

based on heuristic

inferred from title

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

4

object named as

Henry Krum

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

author name string

Arintaya Phrommintikul

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Steven Joseph Haas

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Maros Elsik

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

language of work or name

0 references

publication date

1 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

369

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

9559

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

381-388

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence-based systematic literature review of hemoglobin/hematocrit and all-cause mortality in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Worsening of left ventricular diastolic function during long-term correction of anemia with erythropoietin in chronic hemodialysis patients--an assessment by radionuclide ventriculography at rest and exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of treatment of anaemia with erythropoietin on neuromuscular function in patients on long term haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Normalizing hematocrit in dialysis patients improves brain function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of generic and specific quality-of-life measures in hemodialysis patients treated with erythropoietin. The Canadian Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Correction of anemia with epoetin alfa in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Canadian Randomized Trial of Hemoglobin Maintenance to Prevent or Delay Left Ventricular Mass Growth in Patients With CKD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of early correction of anemia on the progression of CKD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Morbidity and mortality in hemodialysis patients with and without erythropoietin treatment: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Erythropoietin-induced thrombosis as a result of increased inflammation and thrombin activatable fibrinolytic inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Coagulation Studies and Fistula Blood Flow During Erythropoietin Therapy in Haemodialysis Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prothrombotic effect of erythropoietin in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of erythropoietin-induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pooling research results: benefits and limitations of meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Beware the meta-analysis — clozapine and suicidal ideation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Strengths and limitations of meta-analysis: larger studies may be more reliable

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(07)60194-9

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40245317&oldid=1890733219"